Seasonal influenza vaccination of healthy working-age adults: A review of economic evaluations

Drugs

Volumn 72, Issue 1, 2012, Pages 35-48

  Gatwood, Justin ^a   Meltzer, Martin I ^b   Messonnier, Mark ^b   Ortega Sanchez, Ismael R ^b   Balkrishnan, Rajesh ^a   Prosser, Lisa A ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cost effectiveness; Influenza virus infections; Influenza virus vaccine; Sensitivity analysis.

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE; RIMANTADINE;

ABSENTEEISM; ADULT; ANTIVIRAL THERAPY; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; EMERGENCY WARD; FEBRILE BONE MARROW APLASIA; FLU LIKE SYNDROME; HOSPITALIZATION; HUMAN; INFLUENZA VACCINATION; MONTE CARLO METHOD; MORTALITY; OUTPATIENT DEPARTMENT; PRODUCTIVITY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SALARY; SEASONAL INFLUENZA; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; WORKER; WORKING TIME; WORKPLACE;

ADULT; COST-BENEFIT ANALYSIS; EMPLOYMENT; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, ECONOMIC; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 84055190611     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11597310-000000000-00000     Document Type: Review

References (17)

1. Kuehn BM. CDC Advisory committee recommends nearly universal influenza vaccination. JAMA 2010; 303 (12): 1136
2. Fiore AE, Shay DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009 [published erratum appears in MMWR Recomm Rep 2009 Aug 21; 58 (32): 896-7]
3. Bridges CB, Winquist AG, Fukuda K, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000; 49 (RR-3): 1-38
4. Drummond MF, O'Brien BJ, Stoddart GL, et al. Methods for the economic evaluation of health care programmes. 2nd ed. Oxford: Oxford University Press, 1997
5. US Department of Labor, Bureau of Labor Statistics. Consumer Price Index. 2010 [online]. Available from URL: http://www. bls. gov/cpi/#tables [Accessed 2010 Aug 5]
6. Molinari NAM, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25: 5086-96 (Pubitemid 46879994)
7. Nichol KL, Lind A, Margolis KL, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995; 333 (14): 889-93
8. Bridges CB, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 2000; 284 (13): 1655-63
9. Nichol KL, Mallon KP, Mendelman PM. Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. Vaccine 2003; 21: 2207-17
10. Nichol KL. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch Intern Med 2001; 161: 749-59 (Pubitemid 32200231)
11. Lee PY, Matchar DB, Clements DA, et al. Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Ann Intern Med 2002; 137: 225-31
12. Rothberg MB, Rose DN. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis. Am J Med 2005; 118: 68-77 (Pubitemid 40082461)
13. Prosser LA, O'Brien MA, Molinari NAM, et al. Nontraditional settings for influenza vaccination of adults. Pharmacoeconomics 2008; 26 (2): 163-78
14. Hammond ML, Ferris AA, Faine S, et al. Effective protection against influenza after vaccination with subunit vaccine. Med J Aust 1978; 1: 301-3 (Pubitemid 8371637)
15. Keech M, Scott AJ, Ryan PJ. The impact of influenza an influenza-like illness on productivity and healthcare resource utilization in a working population. Occup Med (Lond) 1998; 48: 85-90 (Pubitemid 28077598)
16. Savidan E, Chevat C, Marsh G. Economic evidence of influenza vaccination in children. Health Policy 2008; 86: 142-52 (Pubitemid 351400493)
17. Fiore AE, Fry A, Shay D, et al. Antiviral agents for the treatment and chemoprophylaxis of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60 (RR01): 1-24